Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors
Clinical trial NCT00033241 · COMPLETED
Trial details
- NCT number
- NCT00033241
- Sponsor
- OSI Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2001-07-23
- Primary completion
- 2004-04-22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.